Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
'The Beast in Me' arrives on Netflix: Is it based on a true story? And what drew Claire Danes to it? What to know about the thriller series. - 2Novartis eyes more bolt-on acquisitions, CEO says
- 3Treason trial of South Sudan's suspended VP is further eroding peace deal, UN experts say
- 4The last penny was pressed by the U.S. Mint in Philadelphia today. Could the nickel and dime be next?
- 5Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
- Creativity Revealed: A Survey of \Making Shocking Looks\ Cosmetics Item
- Trump says Cuba is 'ready to fall' after capture of Venezuela's Maduro
- Desired Travel Objections Worldwide: Where to Go Straightaway
- Warning for snow and ice extended
- Instructions to Perform Fundamental Upkeep on Your Slam 1500.
- Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
- 2026 Golden Globes: How to watch, start time, TV channel, full nominee list and more
- Become the best at Discussion: 6 Procedures for Progress
- From Fledgling to Master: Self-awareness in a Side interest
